Technical Insight on Equity Movement – Research on Ignyta, KongZhong, Arbutus Biopharma and Curis

NEW YORK, NY / ACCESSWIRE / November 25, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Ignyta Inc (NASDAQ: RXDX), KongZhong Corporation (NASDAQ: KZ), Arbutus Biopharma Corp (NASDAQ: ABUS) and Curis, Inc. (NASDAQ: CRIS). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

RXDX Research Package: http://www.traders-choice.com/pdf?s=RXDX

KZ Research Package: http://www.traders-choice.com/pdf?s=KZ

ABUS Research Package: http://www.traders-choice.com/pdf?s=ABUS

CRIS Research Package: http://www.traders-choice.com/pdf?s=CRIS

============

Highlights from today’s reports include:

On Tuesday, November 24, 2015, Nasdaq Composite ended at 5,102.81, up 0.01%, Dow Jones advanced 0.11%, to finish the day at 17,812.19, and the S&P closed at 2,089.14, up 0.12%.

– Ignyta Inc’s stock declined 3.76% to close Tuesday’s session at USD 14.09. The share price vacillated between USD 13.70 and USD 14.86. The stock recorded a trading volume of 0.15 million shares, which was below its 50-day daily average volume of 0.26 million shares and below its 52-week average volume of 0.27 million shares. Over the last three days Ignyta Inc’s shares have advanced 7.97% and in the past one week it has moved up 14.65%. Moreover, in the last six months, the stock has gained 46.47% and year to date, the shares have picked up 105.69%. On a compounded total return basis, the stock yielded a return of 47.85% in the last half a year, and 102.73% in the past one year. The Company has a market capitalization of USD 417.34 million and it is trading at Price/Book (mrq) ratio of 3.28.

– KongZhong Corp’s stock edged lower by 0.15% to close Tuesday’s session at USD 6.87. The company’s shares oscillated between USD 6.75 and USD 6.88. The stock recorded a trading volume of 0.07 million shares, which was below its 50-day daily average volume of 0.10 million shares and below its 52-week average volume of 0.14 million shares. Over the last three days, KongZhong Corp’s shares have advanced 1.48% and in the past one week it has moved down 0.29%. Furthermore, over the last three months, the stock has gained 5.86% and in the past six months, the shares have picked up 4.41%. The company is trading at a price to earnings ratio of 73.40. This compares to a historical PE ratio of 11.23. Further, the stock is at a Price/Sales (ttm) ratio of 1.46 and Price/Book (mrq) ratio of 0.95. The Company has a market capitalization of USD 323.25 million.

– The stock of Arbutus Biopharma Corp gained 0.37% to close Tuesday’s session at USD 5.44. The shares of the company moved in the range of USD 5.38 and USD 5.50. A trading volume of 0.15 million shares was recorded, which was lower than its 150-day daily average volume of 0.55 million shares and below its 52-week average volume of 0.69 million shares. Over the last five days, Arbutus Biopharma Corp’s shares have advanced 3.23% while in the past one month it has lost 7.33%. Additionally, over the last three months, the stock has declined 22.06% and in the past six months, the shares have registered a loss of 59.85%. The stock is at a price to book ratio of 4.79. The historical PB ratio is near to 3.86. Further, the stock is trading at a price to sales ratio of 26.30. The Company has a market capitalization of USD 296.86 million.

– Curis Inc’s stock increased by 1.17% to close Tuesday’s session at USD 2.60. The company’s shares fluctuated in the range of USD 2.50 and USD 2.66. A total of 0.23 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.38 million shares and was below its 52-week average volume of 0.87 million shares. Over the last three days Curis Inc’s shares have advanced 4.84% and in the past one week it has moved up 6.12%. Furthermore, over the last three months, the stock has gained 7.00% while in the past six months, the shares have shed 16.67%. The stock is at a price to book ratio of 4.34. The historical PB ratio is near to 4.39. Additionally, the stock is trading at a price to sales ratio of 42.42. The last traded price of the company is above the 50-Day Moving Average of 2.19 but below the 200-Day Moving Average of 2.74.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 434059